Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
9.11
-4.27 (-31.91%)
At close: Jun 27, 2025, 4:00 PM
9.25
+0.14 (1.54%)
After-hours: Jun 27, 2025, 7:43 PM EDT
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $12.07 million as of June 27, 2025. Its market cap has decreased by -36.56% in one year.
Market Cap
12.07M
Enterprise Value
14.09M
1-Year Change
-36.56%
Ranking
Category
Stock Price
$9.11
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $12.07M, a decrease of -94.75%. That is a compound annual growth rate of -43.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 17.73M | 31.25% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 708.10B |
| Johnson & Johnson | 367.24B |
| AbbVie | 329.01B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 274.06B |
| Abbott Laboratories | 240.39B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |